Please login to the form below

Not currently logged in
Email:
Password:

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

Chinese biotechs aim PD-L1 antibody at hepatitis B

Chinese biotechs aim PD-L1 antibody at hepatitis B

viral diseases to Ascletis in China, potentially opening up a new revenue stream for the drug. ... infectious diseases, according to their latest pipeline updates.

Latest news

  • Ex-Pharmacyclics CEO invests $25m in Summit Ex-Pharmacyclics CEO invests $25m in Summit

    says his involvement comes because he holds the company’s “management team and…strategy for developing innovative antibiotics for patients with serious infectious diseases in high-regard.”. ... serious infectious diseases,” said Summit’s CEO

  • UK and EU’s future relationship ‘must protect patients’ UK and EU’s future relationship ‘must protect patients’

    the spread of infectious diseases, according to the coalition, which includes representatives of the NHS and UK pharma's ABPI and biotech association the BIA. ... They want the Declaration to include specific references to the importance of cooperating

  • Novartis culls pipeline to focus on most transformative science Novartis culls pipeline to focus on most transformative science

    Medicines for infectious diseases are among the research projects being abandoned – also part of a worrying trend within in the industry, where commercial incentives are failing to match the urgent clinical ... Jay Bradner. “Society should expect

  • Roche’s new flu pill Xofluza approved in US Roche’s new flu pill Xofluza approved in US

    The US regulator stressed, nevertheless, that flu vaccination was the best way of fighting what is one of the most common, but potentially deadly infectious diseases.

  • Alexion targets RNAi with $637m Dicerna deal Alexion targets RNAi with $637m Dicerna deal

    The drug technology platform produces compounds that inhibit complement activation, and it can be applied across multiple therapeutic areas, including cardiovascular diseases, viral infectious disease and liver diseases. ... With Soliris, Alexion has

More from news
Approximately 3 fully matching, plus 168 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and

  • Searching for health Searching for health

    year. The pharma work is organised into therapeutic areas covering cancers, infectious diseases, immunology, cardiovascular and metabolism diseases with each having dedicated research teams managing all aspects - from finding new compounds

  • The world is our laboratory The world is our laboratory

    Our goal is to improve patient outcomes in the most serious unmet medical needs of our time, including neglected diseases. ... Focused specialties. At Janssen, we have focused our research into five important therapeutic areas: Cardiovascular &Metabolic

  • Deal Watch October 2015 Deal Watch October 2015

    The other ventures are: Onkaido to develop mRNA drugs in oncology; Valera to develop vaccines and therapeutics for the prevention and treatment of viral and bacterial infectious diseases; and Elpidera focused ... 1, 000 ‡. Adheron Therapeutics/ Roche.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and

  • Dr Jan van de Winkel joins Austrian biotech Hookipa Dr Jan van de Winkel joins Austrian biotech Hookipa

    As Hookipa grows and progresses to become an integrated biotech company with multiple clinical programmes in infectious diseases and immune-oncology, Jan’s experience of building companies and his scientific insight

  • Emotive expands client services team Emotive expands client services team

    Biology graduate Rob Mackichan joins the agency as an account manager, bringing experience of working with infectious diseases, rare diseases and medical devices.

  • emotive boosts its client services team emotive boosts its client services team

    Joining as a senior account director, Andy Parry has 9 years’ experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

  • Polyphor appoints new chief medical and development officer Polyphor appoints new chief medical and development officer

    Dr Baker arrives at Polyphor from Novartis, where she held several positions including global head of medical affairs, development head for infectious diseases, transplants and immunology, and global head of clinical

More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics